Carfilzomib
About Carfilzomib
Carfilzomib is a specialised prescription medicine used to treat adults with a type of blood cancer called multiple myeloma. It is typically prescribed when the cancer has returned after previous treatments or has stopped responding to other therapies. This medication plays a vital role in slowing down the progression of cancer cells in the bone marrow.
This medicine is given as an injection directly into your vein (intravenous infusion) by a healthcare professional in a clinic or hospital setting. It is usually given in treatment cycles, meaning you will receive the injection on specific days of the week followed by rest periods. To help your body handle this treatment, drinking plenty of water and staying well-hydrated is one of the most important lifestyle habits you must maintain during your therapy.
While undergoing treatment, you may experience some common side effects such as fatigue, mild nausea, headache, or temporary changes in your blood cell counts. However, you must contact your doctor immediately if you experience serious symptoms like sudden chest pain, shortness of breath, severe dizziness, or swelling in your legs. These can be signs of more serious complications that require prompt medical evaluation.
Do not take this medicine if you are pregnant, as it can cause serious harm to an unborn baby. Before starting your first treatment, you must tell your healthcare provider if you have a history of heart disease, kidney problems, liver conditions, or lung disorders. Your doctor will carefully evaluate your health history to decide if this treatment is safe for you.
This medicine can interact with other prescription drugs, over-the-counter medications, or herbal supplements, so keeping your healthcare team fully informed is essential. It is highly recommended to avoid drinking alcohol during your treatment cycle to prevent putting extra strain on your liver. If you are breastfeeding, elderly, or planning a family, talk to your doctor or pharmacist to understand the specific risks and precautions required.
Uses of Carfilzomib
Medicinal Benefits
This medicine provides meaningful clinical benefits by targeting cancer cells directly, which helps manage the disease more effectively. Key benefits include:
- Slowing Cancer Growth: By stopping cancer cells from dividing, it helps keep the disease in check and delays the progression of multiple myeloma.
- Promoting Remission: When used alongside other therapies, it can help reduce the amount of cancer in the body, leading to longer periods where the disease is inactive.
- Symptom Control: By lowering the overall cancer cell count, it can help relieve associated symptoms such as bone pain, weakness, and extreme tiredness, helping you feel more comfortable.
Directions for Use
- Follow your doctor’s instructions on the dosage and timing of this medication.
- Carfilzomib will be administered by a doctor or nurse in a healthcare facility.
- Do not self-administer.
Storage
Side Effects of Carfilzomib
Common Side Effects (Usually mild):
- Feeling very tired or weak (fatigue)
- Nausea, vomiting, or diarrhea
- Fever, chills, or headache
- Mild shortness of breath during light physical activity
- Low red blood cell counts, which can make you feel pale or weak
Serious Side Effects (Consult your doctor right away):
- Sudden chest pain, tightness, or pressure
- Severe difficulty breathing, coughing up blood, or rapid breathing
- Sudden swelling in your ankles, feet, or hands, or rapid weight gain
- A severe decrease in how much you urinate, or blood in your urine
- Yellowing of your eyes or skin, dark urine, or severe right-sided stomach pain (signs of liver damage)
- Signs of a severe allergic reaction, such as hives, swelling of the face or throat, and trouble swallowing
Medicines Containing this Salt
View AllDrug Warnings
- Check the Solution: Ensure your healthcare provider inspects the vial before use; the mixed solution should be clear and colourless to pale yellow, with no visible particles.
- Monitor Your Weight: Weigh yourself daily at home. Inform your doctor immediately if you experience a sudden weight gain of more than 2 to 3 pounds in a single day, as this can indicate fluid retention or heart strain.
- Keep Blood Pressure Records: Keep a regular log of your blood pressure readings, especially on infusion days, as this medicine can cause sudden blood pressure spikes.
- Stay Consistent with Blood Tests: Attend all scheduled laboratory appointments; regular blood checks are vital to monitor your liver, kidneys, and blood cell counts.
- Avoid Driving After Infusion: Do not drive, operate heavy machinery, or engage in hazardous activities if you feel dizzy, faint, or extremely fatigued immediately after your clinic session.
- Use effective contraception: Women who can become pregnant and male patients with partners who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose. Speak with your doctor about family planning before starting treatment.
- Report infusion reactions immediately: Tell your healthcare team straight away if you develop fever, chills, flushing, chest tightness, shortness of breath, dizziness, or low blood pressure during or shortly after your infusion.
- Watch for blood clots: Seek immediate medical attention if you experience sudden leg pain or swelling, chest pain, or unexplained shortness of breath, as these may be signs of a blood clot.
Drug Interactions
- Medicines that affect kidney function: Taking pain relievers like ibuprofen or naproxen (NSAIDs) alongside Carfilzomib can significantly increase the risk of kidney strain. Always consult your doctor before taking any pain medication.
- Other chemotherapy drugs: Combining this medicine with certain other cancer therapies can increase your risk of low blood cell counts or nerve numbness.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
cautionAvoid alcohol consumption while on treatment with Carfilzomib.
Pregnancy
unsafeCarfilzomib should not be taken during pregnancy as it might cause fetal harm. Inform your doctor immediately if you are conceiving while on therapy.
Breast Feeding
unsafeDo not breastfeed while you are receiving Carfilzomib and for two weeks after your final dose.
Driving
cautionCarfilzomib may cause fatigue, dizziness, fainting, and/or a drop in blood pressure. So, if you have any of these symptoms while in therapy, you should not operate machinery or drive a car.
Liver
cautionExtreme caution is exercised while using Carfilzomib in patients with liver impairment. Inform your doctor if you have liver impairment. Your doctor monitors liver enzymes and withholds dosing if suspected.
Kidney
cautionLimited information is available. Please inform your doctor before prescribing Carfilzomib if you have kidney impairment. Your doctor will weigh the benefits and potential risks before prescribing Carfilzomib.
Children
cautionThe safety and effectiveness of Carfilzomib in pediatric patients have not been established.
Habit Forming
Diet & Lifestyle Advise
- Prioritize Hydration: Drink 6 to 8 glasses of water daily, especially in the 24 to 48 hours before and after each infusion. This helps flush your kidneys and prevents complications from cellular waste.
- Eat Small, Frequent Meals: If you experience nausea or loss of appetite, eating five or six small, nutritious meals throughout the day can be easier to manage than three large ones.
- Practice Infection Prevention: Since this medicine can lower your white blood cell count, wash your hands frequently with soap and water, avoid close contact with sick individuals, and stay away from crowded public spaces when possible.
- Incorporate Gentle Movement: Engage in light activities like short daily walks if your energy levels allow. This can help combat cancer-related fatigue and support your cardiovascular health.
Special Advise
- Pregnancy testing is recommended for females of reproductive potential prior to initiating treatment with Carfilzomib.
- Keep all appointments with your doctor and the laboratory. Your doctor will order laboratory tests before, during and after your treatment to check your body's response to Carfilzomib to see if your blood cells are affected by this drug.
- Do not donate sperm during treatment with Carfilzomib and for three months after your last dose.
Patients Concern
Disease/Condition Glossary
Myeloma, also called multiple myeloma, is a cancer of the plasma cells. Plasma cells are white blood cells that make antibodies that protect us from infection. In myeloma, the cells grow too much, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells. Multiple myeloma, the most common type of plasma cell tumour, develops in the bone marrow and can spread throughout the body.
FAQs
Carfilzomib is used to treat Multiple Myeloma.
Carfilzomib contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.
No, it is unsafe to father a child while taking Carfilzomib. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Carfilzomib.
Based on the medical condition, Carfilzomib may be given alone or together with other medicines used to treat multiple myeloma.
Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.
Carfilzomib can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.
Carfilzomib treats multiple myeloma that has returned or no longer responds to treatment. It's often used with other medications. If you have questions or concerns, talk to your doctor. They will help you understand if Carfilzomib is right for you.
Carfilzomib is to be administered by intravenous infusion in a hospital setting under the supervision of a physician qualified to administer cancer chemotherapeutic agents.
Carfilzomib is given on two consecutive days each week for three weeks followed by a 12-day rest period or it may be given once a week for 3 weeks followed by a 13-day rest period. However, the pattern and duration of treatment may vary. Please consult the doctor if you have any concerns.
You may experience nausea and extreme tiredness from Carfilzomib. To cope with nausea, try eating small meals, avoiding strong smells, and staying hydrated. For tiredness, prioritize rest, break tasks into smaller chunks, and take regular breaks. Practice relaxation techniques like deep breathing, meditation, or yoga, and stay hydrated and energized with nutritious food. However, if these are bothering you consult your doctor immediately.
Carfilzomib can lower your blood cell and platelet counts, increasing the risk of infections, anemia, and bleeding. To keep an eye on this, your doctor will likely order regular blood tests before and during treatment. Consult your doctor if you suspect any symptoms of low immunity like delayed healing or frequent infections.
If you experience any of the following, seek a doctor's advice right away: fever, infection signs, unusual bleeding, shortness of breath, chest pain, severe nausea, weakness, confusion, or severe headache. Also, consult your doctor if you have concerns or questions about your treatment, notice any health changes or side effects, miss a dose, or need to change your treatment schedule.
Carfilzomib should not be taken during pregnancy as it might cause fetal harm. Inform your doctor immediately if you are pregnant or think you may be pregnant while on therapy.
Do not breastfeed while you are receiving Carfilzomib and for two weeks after your final dose as it may pass into the breastmilk. Consult your doctor if you have any concerns regarding it.
Drinking plenty of water is crucial because Carfilzomib can put significant strain on your kidneys as it helps break down cancer cells. Proper hydration helps flush these waste products out of your body safely. Talk to your doctor or pharmacist about how much water you should drink daily.
Warning signs of potential heart complications include sudden chest pain, shortness of breath, rapid weight gain, or swelling in your ankles and feet. If you notice any of these symptoms, seek emergency medical care immediately. Talk to your doctor if you have a history of heart problems.
Carfilzomib is not considered a permanent cure for multiple myeloma, but it is highly effective at controlling the disease, slowing cancer growth, and keeping you in remission for longer periods. Talk to your doctor to understand the realistic goals of your cancer therapy.
You should avoid receiving live vaccines while undergoing treatment with Carfilzomib, as your immune system may be too weak to handle them safely. Non-live vaccines may be safe but could be less effective during chemotherapy. Talk to your doctor or pharmacist before scheduling any vaccinations.
Your doctor will schedule regular blood tests, often before each treatment cycle or even before every dose. These tests check your kidney function, liver health, and blood cell counts to ensure it is safe to proceed with the injection. Talk to your doctor for more details on your monitoring schedule.
It is highly recommended to avoid alcohol while receiving Carfilzomib, as alcohol can worsen treatment-related dehydration, put extra strain on your liver, and increase nausea. Talk to your doctor or pharmacist if you need help managing lifestyle changes during your treatment.
Author Details
